Fate Therapeutics
FATE
FATE
180 hedge funds and large institutions have $401M invested in Fate Therapeutics in 2024 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 57 increasing their positions, 49 reducing their positions, and 22 closing their positions.
Holders
180
Holders Change
+15
Holders Change %
+9.09%
% of All Funds
2.62%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
38
Increased
57
Reduced
49
Closed
22
Calls
$116K
Puts
$48K
Net Calls
+$68K
Net Calls Change
-$1.22M
Top Buyers
1 |
DM
1
Deerfield Management
New York
|
$11.7M |
2 |
2
Citadel Advisors
Miami,
Florida
|
$14.7M |
3 |
3
D.E. Shaw & Co
New York
|
$13.4M |
4 |
VPC
4
Vestal Point Capital
New York
|
$6.56M |
5 |
BBA
5
Baker Bros. Advisors
New York
|
$9.83M |